TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Cannabis Stocks
How to Invest Without Getting Burned: A Tale of 2 Cannabis Earnings
Tech Stocks
3 TSX Stocks That Have Returned 1000% in Under 10 Years
Cannabis Stocks
Should You Buy Canopy Growth Corp (TSX:WEED) Ahead of Earnings?
Stocks for Beginners
Have Investors Overlooked This Weed Company’s Brilliant Strategy?
Cannabis Stocks
2 Pot Stocks to Buy Now and 1 to Avoid
Cannabis Stocks
Is This Cannabis Stock a Better Buy Than Canopy Growth Corp (TSX:WEED)?
Cannabis Stocks
3 Cannabis Stocks to Buy Ahead of 2020
Cannabis Stocks
2 Marijuana Stocks Going Downhill Fast
Tech Stocks
Buying This Stock Could Be Like Buying Canopy Growth (TSX:WEED) in 2014